Introduction: The temporal course of recovery of depressed patients’ cognitive impairment is not fully understood. Methods: We used the California Verbal Learning Test (CVLT) to test declarative memory in 24 depressed patients before and after 35 days of antidepressive treatment as well as after long-term follow-up (> 12 months) in order to relate improvement of depression to recovery of cognitive impairment. Results: Patients with complete remission after 35 days had generally been less impaired at baseline. The disturbance of declarative memory in treatment responders as well as in non-responders did not change from baseline to end of treatment (day 35). However, our results revealed normal values in the CVLT sum score as well as in measures of short- and long-delay free-recall measures in both groups after long-term full remission. Discussion: We conclude that clinical response to antidepressive treatment precedes improvement of declarative memory. A low degree of impairment of declarative memory is associated with early complete remission of depression.
References
-
1
Abas M A, Sahakian B J, Levy R.
Neuropsychological deficits and CT scan changes in elderly depressives.
Psychological Medicine.
1990;
20
507-520
-
2
Alexopoulos G S, Meyers B S, Young R C, Mattis S, Kakuma T.
The course of geriatric depression with reversible dementia: a controlled study.
American Journal of Psychiatry.
1993;
150
1693-1699
-
3 American Psychiatric A ssociation. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC; American Psychiatric Press 1994
-
4
Basso M R, Bornstein R A.
Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task.
Neuropsychology.
1999;
13
557-563
-
5
Beats B C, Sahakian B J, Levy R.
Cognitive performance in tests sensitive to frontal lobe dysfunction in elderly depressed.
Psychological Medicine.
1996;
26
591-603
-
6
Beblo T, Baumann B, Bogerts B, Wallesch C W, Herrmann M.
Neuropsychological correlates of major depression: A short term follow-up.
Cognitive Neuropsychiatry.
1999;
4
33-341
-
7
Beblo T, Herrmann M.
Neuropsychological deficits in depressive disorders.
Fortschritte Neurologie Psychiatrie.
2000;
68
1-11
-
8
Burt D B, Zembar M J, Niederehe G.
Depression and memory impairment: a meta-analysis of the association, its pattern and specifity.
Psychological Bulletin.
1995;
117
285-305
-
9 Caine E D. The neuropsychology of depression: the pseudodementia syndrome. In: I Grant, KM Adams (Eds) Neuropsychological assessment of neuropsychiatric disorders. New York; Oxford University Press 1986: pp 221-243
-
10
Cole M G, Bellavance F, Mansour A.
Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis.
American Journal of Psychiatry.
1999;
156
1182-1189
-
11 Delis D C, Kramer J H, Kaplan E, Ober B A. The California Verbal Learning Test. New York; Psychological Corporation 1987
-
12
Elliott R, Sahakian B J, McKay A P, Herrod J J, Robbins T W, Paykel E.
Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance.
Psychological Medicine.
1996;
26
975-989
-
13
Franke P, Maier W, Hardt J, Frieboes R, Lichtermann D, Hain C.
Assessment of frontal lobe functioning in schizophrenia and unipolar major depression.
Psychopathology.
1993;
26
76-84
-
14
Hagerty B M, Williams R A, Likens S.
Exploration of prodromal symptoms of major depression.
American Journal of Orthopsychiatry.
1997;
67
308-314
-
15
Hamilton M.
A rating scale for depression.
Journal of Neurology, Neurosurgery and Psychiatry.
1960;
23
56-62
-
16
Harvey P D, Powchik P, Parrella M, White L, Davidson M.
Symptom severity and cognitive impairment in chronically hospitalised geriatric patients with affective disorders.
British Journal of Psychiatry.
1997;
170
369-374
-
17
Ilsley J E, Moffoot A PR, O’Carroll R E.
An analysis of memory dysfunction in major depression.
Journal of Affective Disorders.
1995;
35
1-9
-
18
Lupien S J, Nair N PV, Brière S, Maheu F, Tu M T, Lemay M, McEwen B S, Meaney J.
Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life.
Reviews in Neuroscience.
1999;
10
117-139
-
19
McAllister T W, Price T RP.
Severe depressive pseudodementia with and without dementia.
American Journal of Psychiatry.
1982;
139
626-629
-
20
McEwen B, Magarinos A, Reagan L.
Studies of hormone action in the hippocampal formation. Possible relevance to depression and diabetes.
Journal of Psychosomatic Research.
2002;
53
883
-
21
Mitchell A J, Dening T R.
Depression-relatd cognitive impairment: possibilities for its pharmacological treatment.
Journal of Affective Disorders.
1996;
36
79-87
-
22
Niemann H, Köhler S, Sturm W, Willmes K, Gottland S, Saß C.
Der California Verbal Learning Test: Daten zu einer autorisierten deutschen Version.
Zeitschrift für Neuropsychologie.
1999;
10
220-221 (Abstract)
-
23
Paolo A M, Troster A I, Ryan J J.
Test-retest stability of the California verbal learning test in older persons.
Neuropsychology.
1997;
11
613-616
-
24
Purcell P, Maruff P, Kyrios M, Pantelis C.
Neuropsychological function in young patients with unipolar major depression.
Psychological Medicine.
1997;
27
1277-1285
-
25
Richelson E.
Synaptic effects of antidepressants.
Journal of Clinical Psychopharmacology.
1996;
16 (suppl)
1-9
-
26
Tarbuck A F, Paykel E S.
Effects of major depression on the cognitive function of younger and older subjects.
Psychological Medicine.
1995;
25
285-296
-
27
Tham A, Engelbrektson K, Mathe A A, Johnson L, Olsson E, Aberg-Wistedt A.
Impaired neuropsychological performance in euthymic patients with recurring mood disorders.
Journal of Clinical Psychiatry.
1997;
58
26-29
-
28
Trichard C, Martinot J L, Alagille M, Masure M C, Hardy P, Ginestet D, Feline A.
Time course of prefrontal lobe dysfunction in severely depressed in-patients: a longitudinal study.
Psychological Medicine.
1995;
25
79-85
-
29
Ulrich S, Northoff G, Wurthmann C, Partscht G, Pester U, Herscu H, Meyer F P.
Serum levels of amitriptyline and therapeutic effect in non-delusional moderately to severely depressed in-patients.
Pharmacopsychiatry.
2001;
34
33-40
-
30
Van Londen L, Goekoop J G, Zwinderman A H, Lanser J BK, Wiegant V M, de Wied D.
Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression.
Psychological Medicine.
1998;
28
275-284
Michael Deuschle, M.D.
Central Institute of Mental Health
J5, 68159 Mannheim
Germany
Telefon: +49-621-1703-626
Fax: +49-621-1703-891
eMail: deuschle@zi-mannheim.de
